BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20233675)

  • 1. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
    Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
    J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
    Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
    Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR.
    Murphy PG; Henderson DT; Adams MD; Horlick EA; Dixon EP; King LM; Avissar PL; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2009 Mar; 156(1-2):138-44. PubMed ID: 19095009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
    Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
    J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.
    Stevens MP; Rudland E; Garland SM; Tabrizi SN
    J Clin Microbiol; 2006 Jul; 44(7):2428-33. PubMed ID: 16825360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
    Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of molecular assays for detection and typing of human papillomavirus.
    Koidl C; Bozic M; Hadzisejdic I; Grahovac M; Grahovac B; Kranewitter W; Marth E; Kessler HH
    Am J Obstet Gynecol; 2008 Aug; 199(2):144.e1-6. PubMed ID: 18439557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA recovery from Hybrid Capture II samples stored in specimen transport medium with denaturing reagent, for the detection of human papillomavirus by PCR.
    Rabelo-Santos SH; Levi JE; Derchain SF; Sarian LO; Zeferino LC; Messias S; Moraes DL; Campos EA; Syrjänen KJ
    J Virol Methods; 2005 Jun; 126(1-2):197-201. PubMed ID: 15847937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
    Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
    Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.
    Tardif KD; Pyne MT; Malmberg E; Lunt TC; Schlaberg R
    PLoS One; 2016; 11(2):e0149611. PubMed ID: 26905067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflex high-risk human papillomavirus DNA testing (Hybrid Capture 2) of bloody ThinPrep specimens with atypical squamous cells of undetermined significance interpretation: does pretreatment with acetic acid affect test performance?
    Feng J; Husain M
    Cancer; 2005 Dec; 105(6):452-6. PubMed ID: 16080178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
    Eder PS; Lou J; Huff J; Macioszek J
    J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of PCR based detection of human papillomavirus DNA from urine specimens.
    Brinkman JA; Rahmani MZ; Jones WE; Chaturvedi AK; Hagensee ME
    J Clin Virol; 2004 Apr; 29(4):230-40. PubMed ID: 15018850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
    Jamison J; Wilson RT; Carson J
    Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.